Neuropace, Inc. is a medical - devices company in the healthcare sector trading on NASDAQ, led by CEO Joel D. Becker, with a market cap of $568.7M.
Based on Q1 2026 filing
Common questions about Neuropace, Inc.
Neuropace, Inc. (NPCE) has a market capitalization of $568.7M and trades on NASDAQ.
Neuropace, Inc. has approximately 181 employees.